We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Pre-Coated Corning Matrigel Matrix-3D Plates Launched

Pre-Coated Corning Matrigel Matrix-3D Plates Launched content piece image
Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Corning Incorporated has announced the launch of Corning® Matrigel® matrix-3D plates, pre-dispensed with Matrigel matrix to provide a more consistent and convenient, ready-to-use cell culture option to support organoid and spheroid culture models. This new 3D tool aims to help improve productivity by reducing workflow steps and offering added convenience and quality control measures to existing protocols.

Organoid models help create a more life-like environment, resulting in more physiologically relevant data in support of areas such as drug discovery, disease modeling, personalized medicine, and cancer research. The increasing popularity of these 3D models has expanded the demand for technologies that provide consistent and reproducible results. Matrigel matrix has been demonstrated to support both spheroid and organoid models. Dispensing a consistent volume of the Matrigel matrix into 96-well and 384-well microplate formats provides researchers with a tool that allows them to grow and assay cells in the same plate, resulting in robust assay performance and consistent plate-to-plate performance.

“The latest addition to Corning’s portfolio addresses the emerging need for more convenient, consistent Matrigel matrix options as 3D cell culture models migrate into a high throughput environment,” said Kim Titus, director, Business Operations, Corning Life Sciences. “These new tools not only increase convenience and consistency, but also help boost the volume of spheroid and organoid generation and assays essential to advancing research in critical areas such as pancreatic, ovarian, prostate and intestinal diseases.”